Federal award
ROCHE DIAGNOSTICS CORPORATION
W81K0221P0136
Contract
Obligated and Ceiling
- Obligated (net)
- $276,945.12
- Ceiling (potential value, not spending)
- $276,945.12
- Current value
- $276,945.12
- Gross positive obligations
- $362,038.75
Obligated is what the government has committed, net of de-obligations. The ceiling is the most the award or vehicle could ever reach; it is shown separately and never added to, or compared as, spending.
Award Details
- Recipient
- ROCHE DIAGNOSTICS CORPORATION · JDMDFEZBYH36
- Owner company
- Not a reviewed companyNo reviewed company owns this recipient.
- Reported parent
- ROCHE HOLDING AG · WJHDT127L353
- Awarding agency
- Department of War · sub-agency 97DH · office HT9410
- Funding agency
- Department of War · sub-agency 97DH
- Product or service (PSC)
- 6515 · MEDICAL AND SURGICAL INSTRUMENTS, EQUIPMENT, AND SUPPLIES
- Industry (NAICS)
- 325413 · IN-VITRO DIAGNOSTIC SUBSTANCE MANUFACTURING
- PIID
- W81K0221P0136
- Award type code
- B
- Actions
- 13 · Aug 31, 2021 to Apr 14, 2026
- Why it is listed
- gross positive obligations of $100k or more (contracts)
Action History13
| Date | FY | Mod | Action type | Obligation | Company in company totals |
|---|---|---|---|---|---|
| Apr 14, 2026 | FY2026 | P00012 | M | $0.00 | — |
| Mar 31, 2026 | FY2026 | P00011 | M | $0.00 | — |
| Dec 9, 2025 | FY2026 | P00010 | C | $86,490.00 | — |
| Jun 30, 2025 | FY2025 | P00009 | G | −$85,093.63 | — |
| Nov 19, 2024 | FY2025 | P00008 | B | $0.00 | — |
| Oct 29, 2024 | FY2025 | P00007 | C | $78,947.50 | — |
| Jul 16, 2024 | FY2024 | P00006 | G | $0.00 | — |
| Oct 17, 2023 | FY2024 | P00005 | C | $71,912.50 | — |
| May 8, 2023 | FY2023 | P00004 | G | $0.00 | — |
| Nov 9, 2022 | FY2023 | P00003 | C | $65,388.75 | — |
| Aug 2, 2022 | FY2022 | P00002 | G | $0.00 | — |
| Nov 8, 2021 | FY2022 | P00001 | C | $59,300.00 | — |
| Aug 31, 2021 | FY2021 | 0 | — | $0.00 | — |
Newest first. Every obligation is shown as reported, including zero and negative (de-obligation) actions. Award lists belong to the company of the latest action; company totals credit each action to the company named on that row, so a note marks rows where the two differ.